La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Marpai Dividendo

Dividendo criteri di controllo 0/6

Marpai does not have a record of paying a dividend.

Informazioni chiave

n/a

Rendimento del dividendo

n/a

Rapporto di remunerazione

Rendimento medio del settore	1.7%
Prossima data di pagamento dei dividendi	n/a
Data di stacco del dividendo	n/a
Dividendo per azione	n/a
Utile per azione	-US$2.69
Previsione del rendimento del dividendo a 3 anni	n/a

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

Revenues Not Telling The Story For Marpai, Inc. (NASDAQ:MRAI) After Shares Rise 30%

Apr 07

Investors Still Aren't Entirely Convinced By Marpai, Inc.'s (NASDAQ:MRAI) Revenues Despite 34% Price Jump

Feb 16

Market Might Still Lack Some Conviction On Marpai, Inc. (NASDAQ:MRAI) Even After 106% Share Price Boost

Dec 19

Not Many Are Piling Into Marpai, Inc. (NASDAQ:MRAI) Stock Yet As It Plummets 28%

Jun 29

Marpai rallies after directors buy shares

Aug 19

Marpai to acquire Maestro Health for $22.1M

Aug 04

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Insufficient data to determine if MRAI's dividends per share have been stable in the past.

Dividendo in crescita: Insufficient data to determine if MRAI's dividend payments have been increasing.

Rendimento dei dividendi rispetto al mercato

Marpai Rendimento dei dividendi rispetto al mercato

Come si colloca il rendimento da dividendo di MRAI rispetto al mercato?
Segmento	Rendimento dei dividendi
Azienda (MRAI)	n/a
Fondo del 25% del mercato (US)	1.5%
Top 25% del mercato (US)	4.4%
Media del settore (Insurance)	1.7%
Previsione dell'analista in 3 anni (MRAI)	n/a

Dividendo notevole: Unable to evaluate MRAI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Dividendo elevato: Unable to evaluate MRAI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Distribuzione degli utili agli azionisti

Copertura degli utili: Insufficient data to calculate MRAI's payout ratio to determine if its dividend payments are covered by earnings.

Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Unable to calculate sustainability of dividends as MRAI has not reported any payouts.

Marpai Dividendo

Dividendo criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sui dividendi

Recent updates

Marpai, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Marpai, Inc.(OTCPK:MRAI) dropped from S&P TMI Index

Marpai, Inc.(OTCPK:MRAI) dropped from NASDAQ Composite Index

New major risk - Revenue and earnings growth

Independent Director recently sold US$105k worth of stock

Full year 2023 earnings released: US$4.14 loss per share (vs US$5.23 loss in FY 2022)

Consensus revenue estimates decrease by 12%, EPS upgraded

Marpai, Inc. to Report Q1, 2024 Results on May 09, 2024

Marpai, Inc. Announces Executive Appointments

Marpai, Inc. announced that it has received $11.83 million in funding from JGB Management Inc.

Revenues Not Telling The Story For Marpai, Inc. (NASDAQ:MRAI) After Shares Rise 30%

Full year 2023 earnings: EPS misses analyst expectations

Marpai, Inc., Annual General Meeting, May 06, 2024

Nasdaq Panel Grants Marpai's Request for Extension to Comply with Continued Listing Requirements

CEO & Director recently bought US$1.5m worth of stock

Marpai, Inc. announced that it expects to receive $1.5015 million in funding

Marpai, Inc. Provides Impairment Guidance for the Fourth Quarter of 2023

Investors Still Aren't Entirely Convinced By Marpai, Inc.'s (NASDAQ:MRAI) Revenues Despite 34% Price Jump

Marpai, Inc. announced that it has received $1.7 million in funding from Libertas Funding, LLC

Co-Founder & Chairman of the Board recently bought US$193k worth of stock

Marpai, Inc. announced that it expects to receive $1.216464 million in funding

Marpai, Inc. Appoints John Powers as President

New major risk - Shareholder dilution

Market Might Still Lack Some Conviction On Marpai, Inc. (NASDAQ:MRAI) Even After 106% Share Price Boost

Co-Founder & Chairman of the Board recently bought US$99k worth of stock

Marpai, Inc. announced that it expects to receive $0.2955 million in funding

Marpai, Inc. Announces Board Changes

Marpai Receives Delisting Notice from Nasdaq Regarding Non-Compliance with the Market Value of Listed Securities Requirement and its Securities to be Delisted from the Nasdaq Capital Market

CEO & Director recently bought US$239k worth of stock

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Revenue and earnings growth

New major risk - Share price stability

Marpai, Inc. has withdrawn its Follow-on Equity Offering.

Marpai Inc. Announces CEO Changes

Marpai Receives Non-Compliance Notice From Nasdaq

Marpai, Inc. Executes A Separation Agreement with Mr. Lutz Finger, President of Product and Development

New major risk - Market cap size

New major risk - Revenue and earnings growth

Marpai, Inc. Provides Revenue Guidance for the Third Quarter of 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Marpai, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Consensus EPS estimates upgraded to US$2.40 loss

Marpai, Inc. Provides Revenue Guidance for Second Quarter 2023

Marpai Announces Reverse Stock Split in an Effort to Regain Compliance with Nasdaq's Listing Rules

Not Many Are Piling Into Marpai, Inc. (NASDAQ:MRAI) Stock Yet As It Plummets 28%

Marpai, Inc. Launches Marpai Connect Platform to Predict and Help Modify Risk in Healthcare

Marpai, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2023

Marpai, Inc. Hires Gonen Antebi as Chief Operating Officer

Marpai, Inc. Announces Management Changes

Marpai Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price Requirement

Marpai Introduces Chronic Condition Management to Improve Outcomes for Employer Health Plan Members

High number of new and inexperienced directors

Marpai, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Director recently bought US$100k worth of stock

Marpai Launches MarpaiRx Pharmacy Benefit Management Solution to Decrease Prescription Costs

Co-Founder & Chairman of the Board recently bought US$138k worth of stock

Marpai rallies after directors buy shares

Marpai, Inc. (NasdaqCM:MRAI) signed an agreement to acquire Maestro Health for $22.1 million.

Marpai to acquire Maestro Health for $22.1M

Marpai, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Co-Founder & Chairman of the Board recently bought US$105k worth of stock

Marpai, Inc. Provides Revenue Guidance for the Second Quarter of 2022

Marpai, Inc. to Report Q1, 2022 Results on May 11, 2022

High number of new and inexperienced directors

Marpai, Inc., Annual General Meeting, May 31, 2022

Marpai, Inc. Provides Revenue Guidance for the First Quarter of 2022

High number of new and inexperienced directors

Marpai Appoints Lutz Finger as President, Product and Development

Stabilità e crescita dei pagamenti

Rendimento dei dividendi rispetto al mercato

Distribuzione degli utili agli azionisti

Pagamenti in contanti agli azionisti

Scoprire le società che pagano dividendi forti